Crafton Biotechnology Co., Ltd., established in March 2022 in Nagoya, Japan, is a biotechnology company focused on developing novel treatments for cancer, autoimmune, and infectious diseases through its foundational PureCap® technology. PureCap® is a proprietary capping technology to enhance the safety, stability and efficacy of mRNA, that has the potential to improve patient outcome compared to existing technologies. Committed to revolutionizing treatment options, Crafton aims to leverage fully chemically synthesized mRNA to significantly improve patient outcomes on a global scale.
This is some text inside of a div block.
